Reply: To PMID 25631192.
Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.|Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain.
Gemma
G
Tell-Martí
Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain.|Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Joan Anton
JA
Puig-Butille
Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Miriam
M
Potrony
Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain.|Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Celia
C
Badenas
Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain.|Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Montserrat
M
Milà
Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.|Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain.
Josep
J
Malvehy
Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
María José
MJ
Martí
Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
Mario
M
Ezquerra
Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
Rubén
R
Fernández-Santiago
Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.|Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain.|Medicine Department, University of Barcelona (UB), Barcelona, Spain.
Susana
S
Puig
D005260:Female; D020022:Genetic Predisposition to Disease / Q000235:genetics*; D014644:Genetic Variation / Q000235:genetics*; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics*; D010300:Parkinson Disease / Q000235:genetics*; D044102:Receptor, Melanocortin, Type 1 / Q000235:genetics*
D044102:Receptor, Melanocortin, Type 1